Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Joint regional uptake quantification of thorium-227 and radium-223 using a multiple-energy-window projection-domain quantitative SPECT method.

Autor: Li Z, Benabdallah N, Laforest R, Wahl RL, Thorek DLJ, Jha AK

Publikováno v: IEEE transactions on medical imaging [IEEE Trans Med Imaging] 2024 Jul 05; Vol. PP. Date of Electronic Publication: 2024 Jul 05.

Preclinical Evaluation and Pilot Clinical Study of ¹⁸ F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2.

Autor: Ding J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Zhang Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China.; Guizhou University School of Medicine, Guiyang, 550025 Guizhou, China., Jiang J; Department of Radiology, People's Hospital of Deyang City, Deyang, 618000 Sichuan, China., Zhou N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Yu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, 100142 Beijing, China., Wang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Meng X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Daggumati L; Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri 63110, United States., Liu T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Wang F; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Lu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastro-intestinal oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, 100142 Beijing, China., Yang X; Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Street, 100034 Beijing, China., Yang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China., Zhang H; Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri 63110, United States., Thorek DLJ; Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri 63110, United States., Du P; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, 100142 Beijing, China., Zhu H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Beijing 100142, China.

Publikováno v: ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 May 24; Vol. 7 (6), pp. 1758-1769. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).

ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for ²²³ Ra-Based Radiopharmaceutical Therapies.

Autor: Li Z; Department of Biomedical Engineering, Washington University, St. Louis, Missouri., Benabdallah N; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.; Program in Quantitative Molecular Therapeutics, Washington University, St. Louis, Missouri., Luo J; Siteman Cancer Center, Washington University, St. Louis, Missouri.; Division of Public Health Sciences, Department of Surgery, Washington University, St. Louis, Missouri; and.; Division of Biostatistics, Washington University, St. Louis, Missouri., Wahl RL; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.; Siteman Cancer Center, Washington University, St. Louis, Missouri., Thorek DLJ; Department of Biomedical Engineering, Washington University, St. Louis, Missouri.; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.; Program in Quantitative Molecular Therapeutics, Washington University, St. Louis, Missouri.; Siteman Cancer Center, Washington University, St. Louis, Missouri., Jha AK; Department of Biomedical Engineering, Washington University, St. Louis, Missouri; a.jha@wustl.edu.; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.; Siteman Cancer Center, Washington University, St. Louis, Missouri.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 May 01; Vol. 65 (5), pp. 810-817. Date of Electronic Publication: 2024 May 01.

Beyond Average: α-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer.

Autor: Benabdallah N; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Lu P; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri., Abou DS; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Zhang H; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Ulmert D; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Hobbs RF; Department of Radiation Oncology, Johns Hopkins University, Baltimore, Maryland., Gay HA; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Simons BW; Center for Comparative Medicine, Baylor University, Houston, Texas., Saeed MA; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Rogers BE; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Jha AK; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri., Tai YC; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Malone CD; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Ippolito JE; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Michalski J; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Jennings JW; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Baumann BC; Department of Radiation Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.; Department of Radiation Oncology, Springfield Clinic, Springfield, Illinois; and., Pachynski RK; Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, Missouri., Thorek DLJ; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri; thorek.lab@wustl.edu.; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri.; Oncologic Imaging Program, Siteman Cancer Center, Washington University in St. Louis School of Medicine, St. Louis, Missouri.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 245-251. Date of Electronic Publication: 2024 Feb 01.